406 related articles for article (PubMed ID: 17693269)
21. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
[TBL] [Abstract][Full Text] [Related]
22. Critical analysis of 33 patients with peritoneal carcinomatosis secondary to colorectal and appendiceal signet ring cell carcinoma.
Chua TC; Pelz JO; Kerscher A; Morris DL; Esquivel J
Ann Surg Oncol; 2009 Oct; 16(10):2765-70. PubMed ID: 19641972
[TBL] [Abstract][Full Text] [Related]
23. Mucinous colorectal carcinoma: clinical pathology and prognosis.
Okuno M; Ikehara T; Nagayama M; Kato Y; Yui S; Umeyama K
Am Surg; 1988 Nov; 54(11):681-5. PubMed ID: 2847606
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic features of gastric carcinoma patients who undergo a total gastrectomy.
Joo JK; Kim HG; Ryu SY; Lee JH; Kim DY
Int Surg; 2010; 95(2):147-52. PubMed ID: 20718322
[TBL] [Abstract][Full Text] [Related]
25. [Influence of mucinous and signet-ring cell differentiation on epidemiological, histological, molecular biological features, and outcome in patients with colorectal carcinoma].
Benedix F; Kuester D; Meyer F; Lippert H
Zentralbl Chir; 2013 Aug; 138(4):427-33. PubMed ID: 22274919
[TBL] [Abstract][Full Text] [Related]
26. [Clinical features of colorectal mucinous adenocarcinoma].
Song W; He YL; Cai SR; Zhang CH; Chen CQ; Peng JJ; Zhan WH
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):487-90. PubMed ID: 19742341
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder.
Thomas AA; Stephenson AJ; Campbell SC; Jones JS; Hansel DE
Hum Pathol; 2009 Jan; 40(1):108-16. PubMed ID: 18789486
[TBL] [Abstract][Full Text] [Related]
28. Signet ring, high grade, and undifferentiated colorectal adenocarcinomas differ.
Wachtel MS; Haynes AL; Griswold JA
J Surg Res; 2010 Oct; 163(2):250-6. PubMed ID: 20538291
[TBL] [Abstract][Full Text] [Related]
29. The impact of perioperative chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: a multicenter comparative study.
Messager M; Lefevre JH; Pichot-Delahaye V; Souadka A; Piessen G; Mariette C;
Ann Surg; 2011 Nov; 254(5):684-93; discussion 693. PubMed ID: 22005144
[TBL] [Abstract][Full Text] [Related]
30. Clinical outcome of signet ring cell carcinoma and mucinous adenocarcinoma of the colon.
Chen JS; Hsieh PS; Chiang JM; Yeh CY; Tsai WS; Tang R; Changchien CR; Wu RC
Chang Gung Med J; 2010; 33(1):51-7. PubMed ID: 20184795
[TBL] [Abstract][Full Text] [Related]
31. Primary signet-ring cell carcinoma of the colon and rectum: report of eight cases and review of 154 Japanese cases.
Makino T; Tsujinaka T; Mishima H; Ikenaga M; Sawamura T; Nakamori S; Fujitani K; Hirao M; Kashiwazaki M; Masuda N; Takeda M; Mano M
Hepatogastroenterology; 2006; 53(72):845-9. PubMed ID: 17153438
[TBL] [Abstract][Full Text] [Related]
32. [Signet-ring cell colorectal carcinoma. Study of 2 cases].
Fernández Miranda C; Rodríguez Peralto JL; De Prada I; Pulido F; Del Palacio A
Rev Esp Enferm Dig; 1991 Jun; 79(6):425-7. PubMed ID: 1654962
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of mucinous component in colorectal carcinoma.
Papadopoulos VN; Michalopoulos A; Netta S; Basdanis G; Paramythiotis D; Zatagias A; Berovalis P; Harlaftis N
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s123-5. PubMed ID: 15655594
[TBL] [Abstract][Full Text] [Related]
34. Prognosis of Signet Ring Cell Carcinoma of the Colon and Rectum and their Distinction of Mucinous Adenocarcinoma with Signet Ring Cells. A Comparative Study.
Pozos-Ochoa LI; Lino-Silva LS; León-Takahashi AM; Salcedo-Hernández RA
Pathol Oncol Res; 2018 Jul; 24(3):609-616. PubMed ID: 28785968
[TBL] [Abstract][Full Text] [Related]
35. Malignancies of the appendix: beyond case series reports.
McGory ML; Maggard MA; Kang H; O'Connell JB; Ko CY
Dis Colon Rectum; 2005 Dec; 48(12):2264-71. PubMed ID: 16258711
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic strategy for signet ring cell carcinoma of the stomach.
Kunisaki C; Shimada H; Nomura M; Matsuda G; Otsuka Y; Akiyama H
Br J Surg; 2004 Oct; 91(10):1319-24. PubMed ID: 15376179
[TBL] [Abstract][Full Text] [Related]
37. [Epidemiological study, pathologic evaluation and prognostic factors of colorectal mucinous vs non-mucinous adenocarcinoma (a series of 196 patients)].
Arfaoui Toumi A; Kriaa Ben Mahmoud L; Khiari M; Lahmer A; Gharbi L; Dhraïef M; Khalfallah T; Regaya Mzabi S; Bouraoui S
Tunis Med; 2010 Jan; 88(1):12-7. PubMed ID: 20415207
[TBL] [Abstract][Full Text] [Related]
38. [Colon and rectum signet-ring cell carcinoma in the National Institute of Neoplastic Diseases].
Casavilca Zambrano S; Sanchez Lihon J; Zavaleta A
Rev Gastroenterol Peru; 2004; 24(3):234-7. PubMed ID: 15483685
[TBL] [Abstract][Full Text] [Related]
39. Circular tumor growth: a prognostic factor in stage II colorectal carcinoma.
Jimi S; Hotokezaka M; Eto TA; Hidaka H; Maehara N; Chijiiwa K
Hepatogastroenterology; 2008; 55(84):926-9. PubMed ID: 18705299
[TBL] [Abstract][Full Text] [Related]
40. Clinical and pathological prognostic indicators with colorectal mucinous carcinomas.
Kubota K; Akasu T; Fujita S; Sugihara K; Moriya Y; Yamamoto S
Hepatogastroenterology; 2004; 51(55):142-6. PubMed ID: 15011850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
